194 related articles for article (PubMed ID: 23098072)
21. Toll-Like Receptor 2, Toll-Like Receptor 4, Myeloid Differentiation Response Gene 88, and Toll-IL-1 Receptor Domain-Containing Adaptor-Inducing Interferon-γ (TRIF) Selectively Regulate Susceptibility of P0
Brunn A; Mihelcic M; Carstov M; Feind L; Wieser EC; Schmidt J; Utermöhlen O; Deckert M
Am J Pathol; 2017 Jan; 187(1):42-54. PubMed ID: 27842213
[TBL] [Abstract][Full Text] [Related]
22. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
Pinhal-Enfield G; Ramanathan M; Hasko G; Vogel SN; Salzman AL; Boons GJ; Leibovich SJ
Am J Pathol; 2003 Aug; 163(2):711-21. PubMed ID: 12875990
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant for vaccine immunotherapy of cancer--focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity.
Seya T; Shime H; Takeda Y; Tatematsu M; Takashima K; Matsumoto M
Cancer Sci; 2015 Dec; 106(12):1659-68. PubMed ID: 26395101
[TBL] [Abstract][Full Text] [Related]
24. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy.
Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG
Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687
[TBL] [Abstract][Full Text] [Related]
25. Cardiolipin activates antigen-presenting cells via TLR2-PI3K-PKN1-AKT/p38-NF-kB signaling to prime antigen-specific naïve T cells in mice.
Cho JA; Kim TJ; Moon HJ; Kim YJ; Yoon HK; Seong SY
Eur J Immunol; 2018 May; 48(5):777-790. PubMed ID: 29313959
[TBL] [Abstract][Full Text] [Related]
26. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
[TBL] [Abstract][Full Text] [Related]
27. Geometry of a TLR2-Agonist-Based Adjuvant Can Affect the Resulting Antigen-Specific Immune Response.
Wijayadikusumah AR; Zeng W; McQuilten HA; Wong CY; Jackson DC; Chua BY
Mol Pharm; 2019 May; 16(5):2037-2047. PubMed ID: 30924661
[TBL] [Abstract][Full Text] [Related]
28. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.
Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U
Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640
[TBL] [Abstract][Full Text] [Related]
29. Structure based design and synthesis of novel Toll-like Receptor 2 (TLR 2) lipid antagonists.
Natala SR; Habas A; Stocking EM; Orry A; Price DL; Gill MB; Bonhaus DW; Abagyan R; Wrasidlo W
Bioorg Med Chem Lett; 2021 May; 40():127861. PubMed ID: 33636302
[TBL] [Abstract][Full Text] [Related]
30. TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome.
Kwok SK; Cho ML; Her YM; Oh HJ; Park MK; Lee SY; Woo YJ; Ju JH; Park KS; Kim HY; Park SH
Arthritis Res Ther; 2012 Mar; 14(2):R64. PubMed ID: 22417709
[TBL] [Abstract][Full Text] [Related]
31. Regulation of platelet responses triggered by Toll-like receptor 2 and 4 ligands is another non-genomic role of nuclear factor-kappaB.
Rivadeneyra L; Carestia A; Etulain J; Pozner RG; Fondevila C; Negrotto S; Schattner M
Thromb Res; 2014 Feb; 133(2):235-43. PubMed ID: 24331207
[TBL] [Abstract][Full Text] [Related]
32. Targeting the TLR2 Receptor With a Novel Thymopentin-Derived Peptide Modulates Immune Responses.
Wei X; Zhang L; Zhang R; Wu R; Petitte JN; Hou Y; Si D; Ahmad B; Guo H; Zhang M; Cheng Q; Tong Y
Front Immunol; 2021; 12():620494. PubMed ID: 34122400
[TBL] [Abstract][Full Text] [Related]
33. Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy.
Mett V; Komarova EA; Greene K; Bespalov I; Brackett C; Gillard B; Gleiberman AS; Toshkov IA; Aygün-Sunar S; Johnson C; Karasik E; Bapardekar-Nair M; Kurnasov OV; Osterman AL; Stanhope-Baker PS; Morrison C; Moser MT; Foster BA; Gudkov AV
Oncogene; 2018 Jan; 37(4):439-449. PubMed ID: 28967901
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of nuclear factor kappa B as a mechanism of Danshensu during Toll-like receptor 2-triggered inflammation in macrophages.
Ye T; Xiong D; Li Y; Gong S; Zhang L; Li B; Pan J; Qian J; Qu H
Int Immunopharmacol; 2020 Jun; 83():106419. PubMed ID: 32200153
[TBL] [Abstract][Full Text] [Related]
35. Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients.
Dou Y; Jansen DTSL; van den Bosch A; de Man RA; van Montfoort N; Araman C; van Kasteren SI; Zom GG; Krebber WJ; Melief CJM; Woltman AM; Buschow SI
Antiviral Res; 2020 Jun; 178():104746. PubMed ID: 32081741
[TBL] [Abstract][Full Text] [Related]
36. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling.
Bulut Y; Faure E; Thomas L; Equils O; Arditi M
J Immunol; 2001 Jul; 167(2):987-94. PubMed ID: 11441107
[TBL] [Abstract][Full Text] [Related]
37. Pam
Hu HG; Wu JJ; Zhang BD; Li WH; Li YM
Bioconjug Chem; 2020 Nov; 31(11):2499-2503. PubMed ID: 33147965
[TBL] [Abstract][Full Text] [Related]
38. Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group a streptococcal vaccines.
Moyle PM; Dai W; Zhang Y; Batzloff MR; Good MF; Toth I
Bioconjug Chem; 2014 May; 25(5):965-78. PubMed ID: 24712905
[TBL] [Abstract][Full Text] [Related]
39. TLR2 engagement on dendritic cells promotes high frequency effector and memory CD4 T cell responses.
Chandran SS; Verhoeven D; Teijaro JR; Fenton MJ; Farber DL
J Immunol; 2009 Dec; 183(12):7832-41. PubMed ID: 19933854
[TBL] [Abstract][Full Text] [Related]
40. Regulatory and Effector Helper T-Cell Profile after Nerve Xenografting in the Toll-Like Receptor-Deficient Mice.
Rau CS; Lin MW; Wu SC; Wu YC; Lu TH; Tzeng SL; Chen YC; Wu CJ; Hsieh CH
Int J Med Sci; 2015; 12(8):650-4. PubMed ID: 26283885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
